XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Revenues $ 679 $ 716   
Cost of revenues (20) (21)   
Gross profit 659 695   
Research and development expenses (19,906) (12,685) (8,311)
Less participation by the Office of the Chief Scientist and other parties 2,673 3,527 1,682
Research and development expenses, net (17,233) (9,158) (6,629)
General and administrative expenses (5,649) (6,568) (4,485)
Operating loss (22,223) (15,031) (11,114)
Financial income, net 1,068 237 266
Net loss for the period $ (21,155) $ (14,794) $ (10,848)
Loss per share:      
Basic and diluted net loss per share $ (0.38) $ (0.34) $ (0.35)
Weighted average number of shares used in computing basic and diluted net loss per share 55,481,357 44,031,866 31,198,825